Nu Skin Enterprises, Inc. NUS
4.10 USD -0.43 (-9.49%)
At closeNov 6, 2026, 4:00 PM EST
4.10 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
4.09 Day range 4.61
4.09 52-week range 11.67
- YTD
- -57.38%
- 1 year
- -62.14%
News
benzinga.com Nu Skin Enterprises Q3 2026 Earnings Call Transcript Nu Skin Enterprises (NYSE:NUS) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
benzinga.com Nu Skin Enterprises Lowers FY2026 Adj EPS Guidance from $0.70-$0.90 to $0.55-$0.65 vs $0.82 Est; Lowers FY2026 Sales Guidance from $1.280B-$1.350B to $1.260B-$1.290B vs $1.317B Est Nu Skin Enterprises (NYSE:NUS) lowers FY2026 Adj EPS guidance from $0.70-$0.90 to $0.55-$0.65 vs $0.82 analyst estimate. Lowers FY2026 sales outlook from $1.280 billion-$1.350 billion to $1.260…
benzinga.com Nu Skin Enterprises Lowers FY2026 GAAP EPS Guidance from $(4.90)-$(4.73) to $(5.08)-$(4.98) vs $(4.71) Est Nu Skin Enterprises (NYSE:NUS) lowers FY2026 GAAP EPS guidance from $(4.90)-$(4.73) to $(5.08)-$(4.98) vs $(4.71) analyst estimate..- benzinga.com Nu Skin Enterprises Sees Q4 Adj EPS $0.11-$0.21 vs $0.27 Est; Sees Sales $310.000M-$340.000M vs $347.500M Est Nu Skin Enterprises (NYSE:NUS) is looking for Q4 Adj EPS of $0.11-$0.21 vs $0.27 analyst estimate. sees sales of $310.000 million-$340.000 million vs $347.500 million analyst estimate.
- benzinga.com Nu Skin Enterprises Q3 Adj. EPS $0.10 Misses $0.21 Estimate, Sales $311.009M Miss $328.700M Estimate Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.21 by 52.38 percent. This is a 70.59 percent decrease over earnings of…
benzinga.com Nu Skin Enterprises Sees FY2026 Adj EPS $0.70-$0.90 vs $1.00 Est; Lowers FY2026 Sales Guidance from $1.350B-$1.500B to $1.280B-$1.350B vs $1.425B Est Nu Skin Enterprises (NYSE:NUS) is looking for FY2026 Adj EPS of $0.70-$0.90 vs $1.00 analyst estimate. Lowers FY2026 sales outlook from $1.350 billion-$1.500 billion to $1.280 billion-$1.350 billion…- benzinga.com Nu Skin Enterprises Sees Q3 Adj EPS $0.10-$0.20 vs $0.32 Est; Sees Sales $310.000M-$340.000M vs $375.500M Est Nu Skin Enterprises (NYSE:NUS) is looking for Q3 Adj EPS of $0.10-$0.20 vs $0.32 analyst estimate. sees sales of $310.000 million-$340.000 million vs $375.500 million analyst estimate.
- benzinga.com Nu Skin Enterprises Q2 Adj. EPS $0.20, Inline, Sales $320.112M Miss $345.200M Estimate Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.20 per share which met the analyst consensus estimate. This is a 53.49 percent decrease over earnings of $0.43 per share from the same…
benzinga.com Nu Skin Enterprises Stockholders Approve Amended And Restated 2024 Omnibus Incentive Plan; Amended Plan Increases Share Authorization By 2.85M Shares; Plan Termination Date Extended To May 28, 2036 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.(e)On May 28, 2026, at the Nu Skin Enterprises, Inc.…- benzinga.com Nu Skin Enterprises Lowers FY2026 GAAP EPS Guidance from $0.80-$1.20 to $0.70-$1.10 vs $1.00 Est; Affirms FY2026 Sales Guidance of $1.350B-$1.500B vs $1.427B Est Nu Skin Enterprises (NYSE:NUS) lowers FY2026 GAAP EPS guidance from $0.80-$1.20 to $0.70-$1.10 vs $1.00 analyst estimate. Affirms FY2026 sales outlook from $1.350 billion-$1.500 billion to $1.350…
- benzinga.com Nu Skin Enterprises Sees Q2 GAAP EPS $0.15-$0.25 vs $0.23 Est; Sees Sales $330.000M-$360.000M vs $361.000M Est Nu Skin Enterprises (NYSE:NUS) is looking for Q2 GAAP EPS of $0.15-$0.25 vs $0.23 analyst estimate. sees sales of $330.000 million-$360.000 million vs $361.000 million analyst estimate.
- benzinga.com Nu Skin Enterprises Q1 Adj. EPS $0.14 Misses $0.15 Estimate, Sales $320.600M Miss $329.700M Estimate Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.15 by 6.67 percent. This is a 39.13 percent decrease over earnings of…
benzinga.com Nu Skin Enterprises Appoints Chelsea Lantz Interim CFO, Effective Immediately, Succeeding James Thomas Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of Chelsea Lantz as interim Chief Financial Officer, effective immediately. The appointment of Lantz comes after James Thomas…
benzinga.com Nu Skin Enterprises Appoints Chayce Clark COO, Effective Immediately Nu Skin Enterprises Inc. (NYSE:NUS) today announced the appointment of Chayce Clark as chief operating officer effective immediately. Clark will be responsible for leading the company's revenue…
benzinga.com Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session 
benzinga.com Top 3 Defensive Stocks That May Rocket Higher In February 
benzinga.com Nu Skin Stock Sinks After Weak Quarter, Soft Outlook Nu Skin Enterprises Inc (NYSE: NUS) reported Q4 2025 results that missed expectations, with EPS of 29 cents and revenue of $370.32 million.- benzinga.com Nu Skin Enterprises Sees FY2026 Sales $1.350B-$1.500B vs $1.530B Est Nu Skin Enterprises (NYSE:NUS) sees FY2026 sales of $1.350 billion-$1.500 billion vs $1.530 billion analyst estimate.
benzinga.com Nu Skin Enterprises Sees Q1 Sales $320.000M-$340.000M vs $356.800M Est Nu Skin Enterprises (NYSE:NUS) sees Q1 sales of $320.000 million-$340.000 million vs $356.800 million analyst estimate.- benzinga.com Nu Skin Enterprises Q4 EPS $0.29 Misses $0.30 Estimate, Sales $370.320M Miss $382.700M Estimate Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.30 by 3.33 percent. This is a 23.68 percent decrease over earnings of…
benzinga.com Earnings Scheduled For February 12, 2026 
benzinga.com 5 Undervalued Safe-Haven Stocks with Strong Dividends Investors should avoid speculative assets and risky stocks in volatile markets. Safe-haven options like precious metals and consumer staples that offer dividends and show growth potential are…- benzinga.com Nu Skin Enterprises Raises FY2025 GAAP EPS Guidance from $3.05-$3.25 to $3.15-$3.25 vs $3.17 Est Nu Skin Enterprises (NYSE:NUS) raises FY2025 GAAP EPS guidance from $3.05-$3.25 to $3.15-$3.25 vs $3.17 analyst estimate..
- benzinga.com Nu Skin Enterprises Raises FY2025 Adj EPS Guidance from $1.15-$1.35 to $1.25-$1.35 vs $1.26 Est; Narrows FY2025 Sales Guidance from $1.480B-$1.550B to $1.480B-$1.510B vs $1.517B Est Nu Skin Enterprises (NYSE:NUS) raises FY2025 Adj EPS guidance from $1.15-$1.35 to $1.25-$1.35 vs $1.26 analyst estimate. Narrows FY2025 sales outlook from $1.480 billion-$1.550 billion to $1.480…
- benzinga.com Nu Skin Enterprises Sees Q4 GAAP EPS $0.25-$0.35 vs $0.33 Est; Sees Sales $365.000M-$400.000M vs $392.100M Est Nu Skin Enterprises (NYSE:NUS) is looking for Q4 GAAP EPS of $0.25-$0.35 vs $0.33 analyst estimate. sees sales of $365.000 million-$400.000 million vs $392.100 million analyst estimate.
benzinga.com Nu Skin Enterprises Q3 EPS $0.34 Beats $0.30 Estimate, Sales $364.211M Miss $374.200M Estimate Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.30 by 13.33 percent. This is a 100 percent increase over earnings of…
benzinga.com Earnings Scheduled For November 6, 2025 
benzinga.com CORRECTION: Nu Skin Enterprises Q2 EPS $0.43 Beats $0.24 Estimate, Sales $386.138M Beat $376.675M Estimate Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.24 by 79.17 percent. This is a 104.76 percent increase over earnings of…- benzinga.com Nu Skin Enterprises Sees Q3 GAAP EPS $0.25-$0.35 vs $0.29 Est; Affirms Q3 Sales Guidance of $360.00M-$390.00M vs $366.12M Est Nu Skin Enterprises (NYSE:NUS) is looking for Q3 GAAP EPS of $0.25-$0.35 vs $0.29 analyst estimate. Affirms Q3 sales outlook from $360.00 million-$390.00 million to $360.00 million-$390.00 million vs…
- benzinga.com Nu Skin Enterprises Raises FY2025 GAAP EPS Guidance from $2.80-$3.20 to $3.05-$3.20 vs $0.99 Est Nu Skin Enterprises (NYSE:NUS) raises FY2025 GAAP EPS guidance from $2.80-$3.20 to $3.05-$3.20 vs $0.99 analyst estimate..
- benzinga.com Nu Skin Enterprises Raises FY2025 Adj EPS Guidance from $0.90-$1.30 to $1.15-$1.35 vs $0.99 Est; Narrows FY2025 Sales Guidance from $1.48B-$1.62B to $1.48B-$1.55B vs $1.48B Est Nu Skin Enterprises (NYSE:NUS) raises FY2025 Adj EPS guidance from $0.90-$1.30 to $1.15-$1.35 vs $0.99 analyst estimate. Narrows FY2025 sales outlook from $1.48 billion-$1.62 billion to $1.48…
- benzinga.com Earnings Scheduled For August 7, 2025
- benzinga.com Nu Skin Enterprises Sees Q2 GAAP EPS $0.20-$0.30 vs $0.24 Est; Sees Sales $355.000M-$390.000M vs $376.68M Est Nu Skin Enterprises (NYSE:NUS) is looking for Q2 GAAP EPS of $0.20-$0.30 vs $0.24 analyst estimate. sees sales of $355.000 million-$390.000 million vs $376.68 million analyst estimate.
- benzinga.com Nu Skin Enterprises Affirms FY2025 Adj EPS Guidance of $0.90-$1.30 vs $0.99 Est; Affirms FY2025 Sales Guidance of $1.48B-$1.62B vs $1.48B Est Nu Skin Enterprises (NYSE:NUS) affirms FY2025 Adj EPS guidance from $0.90-$1.30 to $0.90-$1.30 vs $0.99 analyst estimate. Affirms FY2025 sales outlook from $1.48 billion-$1.62 billion to $1.48…
- benzinga.com Nu Skin Enterprises Q1 Adj. EPS $0.23 Beats $0.13 Estimate, Sales $364.49M Beat $352.06M Estimate Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.13 by 76.92 percent. This is a 155.56 percent increase over earnings of…
- benzinga.com Earnings Scheduled For May 8, 2025
benzinga.com Nasdaq Surges Above 20,000; Crude Oil Moves Lower 
benzinga.com Dow Falls 100 Points; US Industrial Output Increases In January 
benzinga.com Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday 
benzinga.com Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For February 13, 2025
benzinga.com Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday 
benzinga.com Rivian Automotive, Cerence, Nu Skin Enterprises And Other Big Stocks Moving Higher On Friday 
benzinga.com Why Is Nu Skin Enterprises Stock Jumping Today? Nu Skin's stock rose premarket on Friday following the announcement of its Rhyz subsidiary selling the Mavely platform to Later for $250 million.
benzinga.com Nu Skin Enterprises' Rhyz Subsidiary Sells Mavely Affiliate Marketing Platform To Later For $250M In Cash and Equity, Retains Minority Stake In Combined Later/Mavely Business Approximately $33 million of such consideration will be paid to other equity holders in the Mavely business. In connection with the transaction, Mavely is expected to continue to provide certain…- benzinga.com DA Davidson Maintains Neutral on Nu Skin Enterprises, Lowers Price Target to $7 DA Davidson analyst Linda Bolton Weiser maintains Nu Skin Enterprises (NYSE:NUS) with a Neutral and lowers the price target from $11 to $7.
- benzinga.com Nu Skin Enterprises Q3 2024 GAAP EPS $0.17 Beats $0.14 Estimate, Sales $430.100M Miss $440.954M Estimate Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.14 by 21.43 percent. The company reported quarterly sales of $430.100…
- benzinga.com Nu Skin Introduces MYND360, A New Line Of Clinically Proven Supplements And Topicals For Mental Well-Being MYND360 provides holistic, cognitive support for core areas of mental well-being, including sleep, calm, focus and memoryNu Skin Enterprises (NYSE:NUS), a global beauty and wellness leader, today…
- benzinga.com DA Davidson Maintains Neutral on Nu Skin Enterprises, Lowers Price Target to $11 DA Davidson analyst Linda Bolton Weiser maintains Nu Skin Enterprises (NYSE:NUS) with a Neutral and lowers the price target from $12.5 to $11.
- benzinga.com Citigroup Maintains Neutral on Nu Skin Enterprises, Lowers Price Target to $11.5 Citigroup analyst Chasen Bender maintains Nu Skin Enterprises (NYSE:NUS) with a Neutral and lowers the price target from $14 to $11.5.